The more I think about this, the more I think we need to stop looking at TDOC for comparisons. TDOC takes on clients directly that pay them monthly, and they also have a large employee base that hurts the profitability of the company.
CareClix is providing software to companies (MD.com/Bupa etc) to allow their employees/clients to access doctors via their Phone/PC, etc. If a doctor wants to use/provide CareClix software for their patients, the doctor pays us and I'm sure the user would also pay us whether it's monthly or per visit. (My guess is per visit). But then clients of ours that are offering access to telemedicine we probably offer a rate per employee. We're getting paid every which way I bet.
The software is complete so it's not being built currently. SOLI took the assets and not the debt, so we don't have bills to pay for that. I'm sure we have individuals dealing with the server and any technical issues, and maybe maintenance of the software but all in all we are most likely a pretty efficient and lean team/company.
So with that said, and per the other company linked below that I've posted before, I think we have extremely high margins and I don't think it's out of the realm of possibilities that we could be trading at 50-100x our EPS, if not higher considering the current growth of telemedicine and the HUGE potential for 5-10 years down the road. We might only make $25M a year, but with a $.10 EPS (~40% margin) and a 50x multiple, we're at $5.
News 
Market Data 
Discover 
